QuanDx

Biotechnology, Health Care, Health Diagnostics
Founded in 2010-01-01
Menlo Park, California, United States
http://quandx.com
For Profit

About QuanDx

QuanDx Inc. was founded in September 2010 in New York City, NY, USA. In Jan., 2013, QuanDx moved to Bay area of San Francisco, California, the heart of biotech industry. QuanDx’ vision is to develop and commercialize innovative and unique research / clinical diagnostic assays based on proprietary technology for use in clinical and research laboratories worldwide. Our patented technology is based on innovative Yin-Yang Probes which offer multiple benefits in the design and function of molecular based assays. The first commercial product lines will comprise of Q-Fusion leukemia screening kits, AML/ALL leukemia screening kits, BCR-ABL P210/P190 One-tube Quant kits. The ability to detect cancer specific fusion genes is important not only in cancer research, but also increasingly in clinical settings to ensure that correct diagnosis is made and the optimal personalised treatment is chosen. It is the objective of QuanDx to offer a simpler and cost-effective solution for the detection of these important fusion genes.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 13 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 4250000 USD
  • Last Funding: 3000000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

QuanDx actively uses 13 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Health Diagnostics

Headquarters: Menlo Park, California, United States